PYXS
Pyxis Oncology Inc.
Company Overview
| Mkt Cap | $139.54M | Price | $3.56 |
| Volume | 612.80K | Change | +4.09% |
| P/E Ratio | -1.8 | Open | $3.42 |
| Revenue | $19.1M | Prev Close | $3.42 |
| Net Income | $-77.3M | 52W Range | $0.83 - $5.39 |
| Div Yield | N/A | Target | $6.00 |
| Overall | 63 | Value | 60 |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailyPyxis Oncology Inc. (PYXS) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $3.56 with a market capitalization of $139.54 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows PYXS with a volume of 613K shares. The stock opened down 0.00% from yesterday's close of $3.42. Current analyst estimates project earnings of $-1.34 per share for this year, with next year targeting $-1.3.
PYXS demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for PYXS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 68.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PYXS | $3.56 | +4.1% | 612.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |